Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Wolmark

Showing results (41-50 of 232) with videos related to

Pageof 24
Sort By:
Journal of the National Cancer Institute|April 8, 2004
Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancerSandra M Swain, John W Wilson, Eleftherios P Mamounas, et al.
Retina (Philadelphia, Pa.)|June 4, 2005
Is tamoxifen a risk factor for retinal vaso-occlusive disease?Michael B Gorin, Joseph P Costantino, Destan N Kulacoglu, et al.
Journal of the National Cancer Institute|August 11, 2024
Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trialsJulia Foldi, Neil Carleton, Stewart J Anderson, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 14, 2009
The use of tamoxifen and raloxifene for the prevention of breast cancerD Lawrence Wickerham, Joseph P Costantino, Victor G Vogel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2026
Headwinds in Breast Cancer Research: The Case for Pragmatic Radiotherapy De-escalation StudiesLior Z Braunstein, Melissa P Mitchell, Atif J Khan, et al.
Journal of the National Cancer Institute. Monographs|October 20, 2010
Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention TrialsVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
Cancer|November 27, 2004
Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinomaEdwin R Fisher, Stewart Anderson, Scott Dean, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2024
Correlative Science in the Cooperative Group System: Re-Engineering for SuccessPeter J O'Dwyer, Norman Wolmark, Douglas S Hawkins, et al.
Annals of Surgical Oncology|March 17, 2004
NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trialDavid N Krag, Thomas B Julian, Seth P Harlow, et al.
American Journal of Clinical Pathology|June 21, 2007
Pathologic variables predictive of breast events in patients with ductal carcinoma in situEdwin R Fisher, Stephanie R Land, Reda S Saad, et al.
Pageof 24

Showing results (41-50 of 232) with videos related to

Sort By:
Pageof 24
Journal of the National Cancer Institute|April 8, 2004
Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancerSandra M Swain, John W Wilson, Eleftherios P Mamounas, et al.
Retina (Philadelphia, Pa.)|June 4, 2005
Is tamoxifen a risk factor for retinal vaso-occlusive disease?Michael B Gorin, Joseph P Costantino, Destan N Kulacoglu, et al.
Journal of the National Cancer Institute|August 11, 2024
Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trialsJulia Foldi, Neil Carleton, Stewart J Anderson, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 14, 2009
The use of tamoxifen and raloxifene for the prevention of breast cancerD Lawrence Wickerham, Joseph P Costantino, Victor G Vogel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2026
Headwinds in Breast Cancer Research: The Case for Pragmatic Radiotherapy De-escalation StudiesLior Z Braunstein, Melissa P Mitchell, Atif J Khan, et al.
Journal of the National Cancer Institute. Monographs|October 20, 2010
Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention TrialsVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
Cancer|November 27, 2004
Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinomaEdwin R Fisher, Stewart Anderson, Scott Dean, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2024
Correlative Science in the Cooperative Group System: Re-Engineering for SuccessPeter J O'Dwyer, Norman Wolmark, Douglas S Hawkins, et al.
Annals of Surgical Oncology|March 17, 2004
NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trialDavid N Krag, Thomas B Julian, Seth P Harlow, et al.
American Journal of Clinical Pathology|June 21, 2007
Pathologic variables predictive of breast events in patients with ductal carcinoma in situEdwin R Fisher, Stephanie R Land, Reda S Saad, et al.
Pageof 24